Figure 3.
Internal validation of redox-LPS in test2 cohort. (A) Group division in test2 cohort. (B) Distributions of risk score and survival status in test2 cohort. (C) PCA in test2 cohort. (D) Heatmap about the expression levels of the four lncRNAs involved in the signature in test2 cohort. (E) Survival curve of test2 cohort. (F) ROC curves of test2 cohort